บริษัท เชียงใหม่รามธุรกิจการแพทย์ จำกัด (มหาชน)SET: CMR🇹🇭 TH
This company's most recent 56-1 One Report was filed as a PDF document (spec v3.0), so SET does not publish its section-by-section detail in a machine-readable form. Some information on this site is therefore incomplete.

Financial Information

Key Financial Highlights

As at 2026-09-30 · Unit: M.Baht

Item20242025H1 20269M 2026
Total revenue5,4255,0691,2621,890
Net profit130.512,44640.8670.37
Total assets11,0168,1537,7257,634
Total liabilities5,1383,5893,1253,005
Shareholders' equity3,7694,4994,5414,572
EPS (Baht)0.030.60.010.02
ROE (%)3.259.1660.6566.54
ROA (%)4.1727.882828.07
Net profit margin (%)4.4647.092.93.39
D/E (times)0.870.790.680.65
ItemY/E 2023Dec 2023Y/E 2024Dec 2024Y/E 2025Dec 20256M/2025Jun 20256M/2026Jun 2026
Cash And Cash Equivalents285.43270.95455.13177.8427.16
A/R Net256.08218.0895.16198.6572.68
Inventories118.09129.3852.88130.7160.34
Current Assets1,100.911,048.09907.36988.91624.59
PP&E Net6,916.126,727.153,334.316,751.053,227.96
Non-Current Assets11,281.849,968.387,245.429,495.47,100.86
Total Assets12,382.7511,016.468,152.7710,484.317,725.45
OD1,245.241,225.796901,417.55845.42
A/P Net322.71600.38340.24645.34382.71
Current portion of LT582.64574.17380.88596.54266.99
Current Liabilities3,179.533,212.982,566.833,498.922,167.1
Non-Current Liabilities2,368.71,924.961,022.581,685.36958.26
Total Liabilities5,548.235,137.943,589.415,184.273,125.36
Authorized Capital407.11407.11407.11407.11407.11
Paid-Up Capital407.11407.11407.11407.11407.11
Premium (Discount) on Share Capital124.8124.8124.8124.8124.8
Retained Earnings (Deficit)1,962.781,869.373,990.31,740.084,027.85
Treasury Stock—————
Shares Of The Company Held By Subsidiaries—————
Other Components Of Equity1,880.541,368.05-22.991,143.69-18.94
- Surplus (Deficits)—————
Shareholders' Equity4,375.223,769.334,499.223,415.684,540.82
Minority Interest2,459.32,109.1964.141,884.3659.27

Auditor's Reports

ReportDate of submissionAuditor’s opinionAuditor’s firm
Q2 /202614 Aug 2026Unqualified opinionDHARMNITI AUDITING CO., LTD.
Q1 /202614 May 2026Unqualified opinionDHARMNITI AUDITING CO., LTD.
Yearly 20252 Mar 2026Unqualified opinionDHARMNITI AUDITING CO., LTD.
Q3 /202514 Nov 2025Unqualified opinionDHARMNITI AUDITING CO., LTD.